Epicrispr Biotechnologies vs ReAlta Life Sciences

Epicrispr Biotechnologies vs ReAlta Life Sciences, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and ReAlta Life Sciences on 42/100.

Epicrispr Biotechnologies logo
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Try Epicrispr Biotechnologies
ReAlta Life SciencesDeveloping novel therapeutics for inflammatory and hypoxic diseases.
Try ReAlta Life Sciences

Where each one leads

Epicrispr Biotechnologies

  • our overall score: 62/100 against 42/100
  • agent readiness: 39/100 against 25/100
  • funding raised: $90.0M against $55.0M

ReAlta Life Sciences

Leads on none of the measures we hold for both companies.

At a glance

MeasureEpicrispr BiotechnologiesReAlta Life Sciences
What it isEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).Developing novel therapeutics for inflammatory and hypoxic diseases.
CategoryBiotechnology, Therapeutics, Rare Diseases, EpigeneticsBiotechnology, Pharmaceuticals, Healthcare, Biotech
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20202016
HeadquartersSouth San Francisco, United StatesNorfolk, USA
StatusActiveActive

Size, funding and growth

MeasureEpicrispr BiotechnologiesReAlta Life Sciences
Employees51Not published
Total funding$90.0M$55.0M
Latest roundSeries CFunding Round
LinkedIn followers7,025Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEpicrispr BiotechnologiesReAlta Life Sciences
StartupHub scoreOur 0-100 rating62/10042/100
Traction57/10039/100
Team40/100Not published
Search visibility20/10013/100
Quality78/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (25/100)
Domain ratingLink authority, 0-10040/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEpicrispr BiotechnologiesReAlta Life Sciences
CDNCloudflareNot detected
CMSWordPressNot detected
FrameworksJquery, Tailwind CSS, BootstrapNot detected
AnalyticsGoogle Analytics 4Not detected

Epicrispr Biotechnologies vs ReAlta Life Sciences: common questions

Which is better, Epicrispr Biotechnologies or ReAlta Life Sciences?

On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.

How do Epicrispr Biotechnologies and ReAlta Life Sciences compare on the numbers?

Epicrispr Biotechnologies leads on our overall score (62/100 against 42/100), agent readiness (39/100 against 25/100), funding raised ($90.0M against $55.0M).

Read the full Epicrispr Biotechnologies review and pricing or the ReAlta Life Sciences review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.